December 8, 2025 PRNewswire NES ZIONA, Israel, Dec. 8, 2025 /PRNewswire/ — EyeYon Medical Ltd., a global leader in ophthalmic innovation, today announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to initiate a U.S. clinical study of EndoArt®, the world’s first synthetic endothelial layer for the treatment of chronic corneal edema. EndoArt®...Read More
Published: 2025-03-20 News provided by EyeYon Medical 20 Mar, 2025, 11:00 IST NES ZIONA, Israel, March 20, 2025 /PRNewswire/ — EyeYon Medical, a global leader in innovative corneal implant solutions, is proud to announce that Dr. Ofer Daphna, the inventor of EndoArt®, will deliver an invited keynote lecture at the prestigious World Cornea Congress (WCC)...Read More
Published: 2025-02-05 2025-02-05 09:00 ZHUHAI, China, Feb. 5, 2025 /PRNewswire/ — EyeYon Medical is proud to announce its expansion in China with the establishment of a new subsidiary, Zhuhai EyeYon Medical Technology Co., Ltd. (珠海爱眼医疗科技有限公司), which will address unmet market needs as well as accelerate its growth trajectory. This strategic move underscores a significant commitment to expanding its reach and impact in a...Read More
Published: 2024-06-04 Cecil Farley who has an artificial cornea in his right eye Credit: PA A 91-year-old man has made history by becoming the first patient in England to receive an artificial cornea. Cecil Farley faced a year-long wait for sight-saving surgery after a human cornea transplant failed, but his surgeon offered him the chance to...Read More
